Stroke and renal dysfunction

European Journal of Internal Medicine

Volumn 25, Issue 1, 2014, Pages 18-24

  Hojs Fabjan, Tanja ^a,b   Hojs, Radovan ^a,b  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

^b UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

Chronic kidney disease; End stage renal failure; Mortality; Renal dysfunction; Stroke

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; BLOOD CLOTTING INHIBITOR; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ALBUMINURIA; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; END STAGE RENAL DISEASE; FIBRINOLYTIC THERAPY; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; INCIDENCE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MORBIDITY; PREVALENCE; PROTEINURIA; PUBLIC HEALTH PROBLEM; SUBSTITUTION THERAPY;

CHRONIC KIDNEY DISEASE; END-STAGE RENAL FAILURE; MORTALITY; RENAL DYSFUNCTION; STROKE;

ANTICOAGULANTS; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY;

EID: 84892780843     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.08.710     Document Type: Review

References (75)

1. R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, and V. Aboyans et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2095 2128
2. V. Jha, G. Garcia-Garcia, K. Iseki, Z. Li, S. Naicker, and B. Plattner et al. Chronic kidney disease: global dimension and perspectives Lancet 2013 10.1016/S0140-6736(13)60687-X [doi:pii: S0140-6736(13)60687-X]
3. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative Am J Kidney Dis 39 2002 S1 S246
4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD work group KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease Kidney Int 3 2013 1 150
5. R.N. Foley, P.S. Parfrey, and M.J. Sarnak The clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 1998 S112 S119
6. R. Hojs, T. Hojs-Fabjan, and B. Pečovnik-Balon Atherosclerosis in patients with end-stage renal failure prior to initiation of hemodialysis Ren Fail 25 2003 247 254
7. A.X. Garg, W.F. Clark, R.B. Haynes, and A.A. House Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I Kidney Int 61 2002 1486 1494
8. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
9. M. Cirillo, M.P. Lanti, A. Menotti, M. Laurenzi, M. Mancini, and A. Zanchetti et al. Definition of kidney dysfunction as a cardiovascular risk factor: use of urinary albumin excretion and estimated glomerular filtration rate Arch Intern Med 168 2008 617 624
10. D.S. Keith, G.A. Nichols, C.M. Gullion, J.B. Brown, and D.H. Smith Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Arch Intern Med 164 2004 659 663
11. T. Kawagishi, Y. Nishizawa, T. Konishi, K. Kawasaki, M. Emoto, and T. Shoji et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia Kidney Int 48 1995 820 826
12. R. Hojs Carotid intima-media thickness and plaques in hemodialysis patients Artif Organs 9 2000 691 695
13. E. Preston, M.R. Ellis, E. Kulinskaya, A.H. Davies, and E.A. Brown Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD Am J Kidney Dis 46 2005 856 862
14. R. Ekart, R. Hojs, S. Bevc, and B.P. Balon Asymptomatic atherosclerosis and hypertension in nondiabetic patients with chronic kidney disease Artif Organs 32 2008 220 225
15. A.P. Guerin, G.M. London, S.J. Marchais, and F. Metivier Arterial stiffness and vascular calcifications in end-stage renal disease Nephrol Dial Transplant 15 2000 1014 1021
16. G.M. London Arterial calcification: cardiovascular function and clinical outcome Nefrologia 31 2011 644 647
17. A.S. Levey Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start? Am J Kidney Dis 32 1998 S5 S13
18. S.L. Seliger Stroke in ESRD: the other cardiovascular disease Am J Kidney Dis 54 2009 403 405
19. C.E. Mogensen Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes N Engl J Med 310 1984 356 360
20. W.B. Kannel, M.J. Stampfer, W.P. Castelli, and J. Verter The prognostic significance of proteinuria: the Framingham study Am Heart J 108 1984 1347 1352
21. D. de Zeeuw, H.H. Parving, and R.H. Henning Microalbuminuria as an early marker for cardiovascular disease J Am Soc Nephrol 17 2006 2100 2105
22. M. Nakano, M. Nojiri, and H. Arai Correlation of cerebrocardiovascular findings to mortality of middle-aged and elderly in a population from a fishing village in Shizuoka Prefecture Nippon Koshu Eisei Zasshi 37 1990 21 32
23. T. Nakayama, C. Date, T. Yokoyama, N. Yoshiike, M. Yamaguchi, and H. Tanaka A 15.5-year follow-up study of stroke in a Japanese provincial city: the Shibata study Stroke 28 1997 45 52
24. H. Miettinen, S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects Stroke 27 1996 2033 2039
25. N.B. Beamer, B.M. Coull, W.M. Clark, and M. Wynn Microalbuminuria in ischemic stroke Arch Neurol 56 1999 699 702
26. M. Lee, J.L. Saver, K.H. Chang, H.W. Liao, S.C. Chang, and B. Ovbiagele Impact of microalbuminuria on incident stroke: a meta-analysis Stroke 41 2010 2625 2631
27. D.E. Weiner, H. Tighiouart, M.G. Amin, P.C. Strk, B. Macleod, and J.L. Griffith et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies J Am Soc Nephrol 15 2004 1307 1315
28. T.L. Nickolas, M. Khatri, B. Boden-Albala, K. Kiryluk, X. Luo, and P. Gervasi-Franklin et al. The association between kidney disease and cardiovascular risk in a multiethnic cohort: findings from the Northern Manhattan Study (NOMAS) Stroke 39 2008 2876 2879
29. M.J. Bos, P.J. Koudstaal, A. Hofman, and M.M.B. Breteler Ischemic stroke: the Rotterdam study decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke Stroke 38 2007 3127 3132
30. Eastern Stroke Coronary Heart Disease Collaborative Research Blood pressure, cholesterol, and stroke in eastern Asia Lancet 352 1998 1801 1807
31. M. Nakayama, H. Metoki, H. Terawaki, T. Ohkubo, M. Kikuya, and T. Sato et al. Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population - the Ohasama study Nephrol Dial Transplant 22 2007 1910 1915
32. T. Ninomiya, Y. Kiyohara, Y. Tokuda, Y. Doi, H. Arima, and A. Harada et al. Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study Circulation 118 2008 2694 2701
33. M.G. Shlipak, J.A. Simon, D. Grady, F. Lin, N.K. Wenger, and C.D. Furberg Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease J Am Coll Cardiol 38 2001 705 711
34. N.S. Anavekar, J. McMurray, E. Velazquez, S.D. Solomon, L. Kober, and J.L. Rouleau et al. Relationship between renal function and cardiovascular outcomes after myocardial infarction N Engl J Med 351 2004 1285 1295
35. M. Lee, J.L. Saver, K.H. Chang, H.W. Liao, S.C. Chang, and B. Ovbiagele Low glomerular filtration rate and risk of stroke: metaanalysis BMJ 341 2010 c4249
36. K. Iseki, K. Kinjo, Y. Kimura, A. Osawa, and K. Fukiyama Evidence for high risk of cerebral hemorrhage in chronic dialysis patients Kidney Int 44 1993 1086 1090
37. M. Kawamura, S. Fijimoto, S. Hisanaga, Y. Yamamoto, and T. Eto Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis Am J Kidney Dis 31 1998 991 996
38. Investigators WMPP The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration J Clin Epidemiol 41 1988 105 114
39. D.A. Goodkin, D.L. Mapes, and P.J. Held The Dialysis Outcomes and Practice Patterns Study (DOPPS): how can we improve the care of hemodialysis patients? Semin Dial 14 2001 157 159
40. S.L. Seliger, D.L. Gillen, W.T. Longstreth Jr., B. Kestenbaum, and C.O. Stehman-Breen Elevated risk of stroke among patients with end-stage renal disease Kidney Int 64 2003 603 609
41. D.A. Goodkin, J.L. Bragg-Gresham, K.G. Koenig, R.A. Wolfe, T. Akiba, and V.E. Andreucci et al. Association of co-morbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS) J Am Soc Nephrol 14 2003 3270 3277
42. C. Wanner, V. Krane, W. Marz, M. Olschewski, J.F. Mann, and G. Ruf et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 2005 238 248
43. B.C. Fellstrom, A.G. Jardine, R.E. Schmieder, H. Holdaas, K. Bannister, and J. Beutler et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis N Engl J Med 360 2009 1395 1407
44. K. Toyoda, K. Fujii, S. Fujimi, Y. Kumai, H. Tsuchimochi, and S. Ibayashi et al. Stroke in patients on maintenance hemodialysis: a 22-year single-center study Am J Kidney Dis 45 2005 1058 1066
45. J.A. Delmez, G. Yan, J. Bailey, G.J. Beck, S. Beddhu, and A.K. Cheung et al. Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO study Am J Kidney Dis 47 2006 131 138
46. S.M. Sozio, P.A. Armstrong, J. Coresh, B.G. Jaar, N.E. Fink, and L.C. Plantinga et al. Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study Am J Kidney Dis 54 2009 468 477
47. H.P. Adams Jr., B.H. Bendixen, L.J. Kappelle, J. Biller, B.B. Love, and D.L. Gordon et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 1993 35 41
48. C. Sanchez-Perales, E. Vazquez, J. Garcia-Cortes, J. Borrego, M. Polaina, and P.C. Gutierrez et al. Ischaemic stroke in incident dialysis patients Nephrol Dial Transplant 25 2010 3343 3348
49. G. Ocak, K.J. van Stralen, F.R. Rosendaal, M. Verduijn, P. Ravani, and R. Palsson et al. Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients J Thromb Haemost 10 2012 2484 2493
50. H.P. Adams Jr., G. Dawson, T.J. Coffman, and R.J. Corry Stroke in renal transplant recipients Arch Neurol 43 1986 113 115
51. A. Oliveras, J. Roquer, J.M. Puig, A. RodrIguez, M. Mir, and A. Orfila et al. Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome Clin Transplant 17 2003 1 8
52. K.L. Lentine, L.A. Rocca Rey, S. Kolli, G. Bacchi, M.A. Schnitzler, and K.C. Abbott et al. Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure Clin J Am Soc Nephrol 3 2008 1090 1101
53. G. Tsagalis, T. Akrivos, M. Alevizaki, E. Manios, K. Stamatellopoulos, and A. Laggouranis et al. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality Nephrol Dial Transplant 24 2009 194 200
54. G. Yahalom, R. Schwartz, Y. Schwammenthal, O. Merzeliak, M. Toashi, and D. Orion et al. Chronic kidney disease and clinical outcome in patients with acute stroke Stroke 40 2009 1296 1303
55. Y. Tsukamoto, W. Takahashi, S. Takizawa, S. Kawada, and S. Takagi Chronic kidney disease in patients with ischemic stroke J Stroke Cerebrovasc Dis 21 2012 547 550
56. S. Matsuo, E. Imai, M. Horio, N. Ura, S. Ito, and H. Sato et al. Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 2009 982 992
57. D. Zimmerman, M.M. Sood, C. Rigatto, R.M. Holden, S. Hiremath, and C.M. Clase Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis Nephrol Dial Transplant 27 2012 3816 3822
58. K.P. Ng, N.C. Edwards, G.Y. Lip, J.N. Townend, and C.J. Ferro Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation Am J Kidney Dis 2013 10.1053/j.ajkd.2013.02.381 [pii: S0272-6386(13)00784-1, Epub ahead of print]
59. A.S. Go, M.C. Fang, N. Udaltsova, Y. Chang, N.K. Pomernacki, and L. Borowsky et al. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study Circulation 17 2009 1363 1369
60. K. Ueda, Y. Watanabe, T. Katsumata, T. Kaneko, T. Otori, and K. Utsumi et al. Carotid intima-media thickness and cerebral white matter lesions are more advanced in acute ischemic stroke patients with renal dysfunction Clin Nephrol 76 2011 290 295
61. M. Kamouchi Stroke features and management in patients with chronic kidney disease Contrib Nephrol 179 2013 92 99
62. M.A. Ikram, M.W. Vernooij, A. Hofman, W.J. Niessen, A. van der Lugt, and M.M. Breteler Kidney function is related to cerebral small vessel disease Stroke 39 2008 55 61
63. Y. Yamamoto, T. Ohara, Y. Nagakane, E. Tanaka, F. Morii, and T. Koizumi et al. Chronic kidney disease, 24-h blood pressure and small vessel diseases are independently associated with cognitive impairment in lacunar infarct patients Hypertens Res 34 2011 1276 1282
64. M. Kurella Tamura, V. Wadley, K. Yaffe, L.A. McClure, G. Howard, and R. Go et al. Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study Am J Kidney Dis 52 2008 227 234
65. T. Hojs Fabjan, R. Hojs, E. Tetickovic, and Balon B. Pecovnik Ischaemic stroke - impact of renal dysfunction on in-hospital mortality Eur J Neurol 14 2007 1351 1356
66. R.S. MacWalter, S.Y.S. Wong, and K.Y.K. Wong Does renal dysfunction predict mortality after acute stroke?: a 7-year follow-up study Stroke 33 2002 130 135
67. B. Ovbiagele Chronic kidney disease and risk of death during hospitalization for stroke J Neurol Sci 301 2011 46 50
68. V. Agrawal, B. Rai, J. Fellows, and P.A. McCullough In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke Nephrol Dial Transplant 25 2010 1150 1157
69. M. Naganuma, M. Koga, Y. Shiokawa, J. Nakagawara, E. Furui, and K. Kimura et al. Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry Cerebrovasc Dis 31 2011 123 129
70. A. Power, D. Epstein, D. Cohen, R. Bathula, J. Devine, and A. Kar et al. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke Cerebrovasc Dis 35 2013 45 52
71. W.C. Winkelmayer, A.R. Patrick, J. Liu, M.A. Brookhart, and S. Setoguchi The increasing prevalence of atrial fibrillation among hemodialysis patients J Am Soc Nephrol 22 2011 349 357
72. M.J. Elliott, D. Zimmerman, and R.M. Holden Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates Am J Kidney Dis 50 2007 433 440
73. S. Genovesi, and A. Santoro Anticoagulants, renal failure and atrial fibrillation Expert Opin Drug Saf 12 2013 1 3
74. J.B. Olesen, G.Y. Lip, A.L. Kamper, K. Hommel, L. Køber, and D.A. Lane et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease N Engl J Med 367 2012 625 635
75. I. Salim, J. Al Suwaidi, W. Ghadban, and A.M. Salam Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety Expert Opin Drug Saf 12 2013 53 63